How can we help you?

Drug Provides Relief For Fibromyalgia Patients

Trinity Health

(MINOT, ND)
People who suffer from fibromyalgia finally have a source of relief. A drug approved by the FDA in 2007 is having a positive impact on patients locally, according to Erdal Diri, MD, a rheumatologist with Trinity Medical Group.

Dr. Diri (DEER-i) participated in one of the early trials of the drug, pregabalin (pre-GA-ba-lin), which is sold under the brand name Lyrica (LEER-i-ca). The multi-center study of 750 fibromyalgia patients found that those treated with pregabalin showed improvements in pain scores and sleep outcomes. The results appeared in the September 2008 issue of The Journal of Pain.

Pregabalin has become an important treatment option for my patients,” Dr. Diri reports. “”It’s been quite effective; patients have done very well. It’s now become the most common treatment for people with fibromyalgia.””

Fibromyalgia is a syndrome characterized by widespread pain

About the Author

Trinity Health, a comprehensive healthcare system based in Minot, ND, proudly serves the North Dakota, Eastern Montana, and Saskatchewan region. Delivering care as advanced as it is personal, we offer the latest technology and dedicated, compassionate teams to care for you and your family. Maybe you’re looking for a new provider. Starting a new family. Seeking new treatment options. Wherever you are in life, Trinity Health is here for you.